(MENAFN- EIN Presswire) Liquid Biopsy Market1
PORTLAND, OR, UNITED STATE, March 28, 2023 /einpresswire.com / -- liquid biopsy market - Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2030). The market Study is segmented by key a region that is accelerating the marketization. The report provides information on market research and development, growth drivers, and the changing investment structure of the Global Liquid Biopsy Market. Some of the key players profiled in the study are Bio-Rad Laboratories, Inc, Biocept Inc., Guardant Health Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd. (FOUNDATION MEDICINE, INC.), Johnson & Johnson, Laboratory Corporation of America Holdings, MDxHealth SA, QIAGEN N.V., and Thermo Fisher Scientific Inc.
Click To get FREE SAMPLE PDF (Including Full TOC, Table & Figures):
Liquid biopsy is a non-invasive diagnostic procedure that involves the analysis of various biomarkers such as DNA, RNA, proteins, and other substances in a patient's blood, urine, or other body fluids. Liquid biopsy is used to detect and monitor various types of cancers and other diseases.
In cancer diagnosis, liquid biopsy allows doctors to detect and analyze cancer cells or cancer-related molecules that are circulating in a patient's blood or other body fluids. This technique can be used to identify cancer at an early stage, monitor the progress of the disease, and even track the effectiveness of cancer treatments. Liquid biopsy is also used in the diagnosis and monitoring of other diseases such as infectious diseases, cardiovascular disease, and neurological disorders.
Liquid Biopsy Market Statistics: The global Liquid Biopsy market is estimated to reach at $6,804.90 million by 2028, registering a CAGR of 20.9% from 2021 to 2028.
Liquid Biopsy Market: Demand Analysis & Opportunity Outlook 2030
Liquid Biopsy research study defines market size of various segments & countries by historical years and forecast the values for next 7 years. The report is assembled to comprise qualitative and quantitative elements of Liquid Biopsy industry including: market share, market size (value and volume 2017-2021, and forecast to 2030) that admires each country concerned in the competitive marketplace. Further, the study also caters and provides in-depth statistics about the crucial elements of Liquid Biopsy which includes drivers & restraining factors that helps estimate future growth outlook of the market.
Marketing Communication and Sales Channel
Understanding“marketing effectiveness” on a continual basis, help determine the potential of advertising and marketing communications and allow to use of best practices to utilize untapped audience. In order to make marketers make effective strategies and identify why the target market is not giving attention, we ensure the Study is Segmented with appropriate marketing & sales channels to identify potential market size by value & Volume* (if Applicable).
Have Any Query? Ask Our Expert @:
The segments and sub-section of Liquid Biopsy market is shown below:
By Product & Service: Kits & Reagents, Platforms & Instruments, and Services
By Circulating Biomarker: Circulating Tumor Cells, Extracellular Vesicles, Circulating Tumor DNA [ctDNA], and Other Biomarkers
By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Other Cancers
By End User: Hospitals & Laboratories and Government & Academic Research Centers
Some of the key players involved in the Market are: Bio-Rad Laboratories, Inc, Biocept Inc., Guardant Health Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd. (FOUNDATION MEDICINE, INC.), Johnson & Johnson, Laboratory Corporation of America Holdings, MDxHealth SA, QIAGEN N.V., and Thermo Fisher Scientific Inc.
Important years considered in the Liquid Biopsy study:
Historical year – 2017-2021; Base year – 2021; Forecast period** – 2022 to 2030 [** unless otherwise stated]
If opting for the Global version of Liquid Biopsy Market; then below country analysis would be included:
– North America (USA, Canada and Mexico)
– Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland and Rest of Europe)
– Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and Rest of APAC)
– South America (Brazil, Argentina, Chile, Colombia, Rest of countries etc.)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)
Key Questions Answered with this Study:
1) What makes Liquid Biopsy Market feasible for long term investment?
2) How influencing factors driving the demand of Liquid Biopsy in next few years?
3) Territory that may see steep rise in CAGR & Y-O-Y growth?
4) What geographic region would have better demand for product/services?
5) What opportunity emerging territory would offer to established and new entrants in Liquid Biopsy market?
6) What strategies of big players help them acquire share in mature market?
7) Know value chain areas where players can create value?
8) What is the impact analysis of various factors in the Global Liquid Biopsy market growth?
9) Risk side analysis connected with service providers?
Introduction about Liquid Biopsy Market
Liquid Biopsy Market Size (Sales) Market Share by Type (Product Category)
Liquid Biopsy Market by Application/End Users
Liquid Biopsy Sales (Volume) and Market Share Comparison by Applications
Global Liquid Biopsy Sales and Growth Rate (2020-2030)
Liquid Biopsy Competition by Players/Suppliers, Region, Type, and Application
Liquid Biopsy (Volume, Value, and Sales Price) table defined for each geographic region defined.
Liquid Biopsy Players/Suppliers Profiles and Sales Data
Key Raw Materials Analysis & Price Trends
Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis
........and view more in complete table of Contents
Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @
Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.
David Correa
Allied Analytics LLP
+1-800-792-5285
email us here